USA/SF. Direct to Inject Buprenorphine Guideline
USA/SF. Direct to Inject Buprenorphine Guideline
SCOPE: This Direct to Inject (DTI) Buprenorphine Guideline is intended to offer prescribing assistance for providers, patients and the interested general public to increase the effectiveness and safety of medication for opioid use disorder (MOUD) in the ambulatory care setting. It is not intended to be comprehensive in scope. These recommendations are not a substitute for clinical judgment, and decisions about care must carefully consider and incorporate the clinical characteristics and circumstances of each individual patient. References can be found in the Opioid Use Disorder References and Further Reading. (San Francisco Department of Public Health, Behavioral Health Services, Medication Use Improvement Committee, 05.03.2026)
https://media.api.sf.gov/documents/Direct_to_Inject_Buprenorphine_Guideline.cleaned.pdf